Article Details
Retrieved on: 2022-10-18 15:09:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
San Francisco-based Vir Biotechnology, Inc. announced that the Phase 2 PENINSULA trial evaluating VIR-2482 was designed to be a universal ...
Article found on: www.precisionvaccinations.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here